There are 2 dimensions to patient centeredness of diabetes care that Lonny Reisman, MD, the founder and chief executive officer of HealthReveal, will focus on during his keynote speech at Patient-Centered Diabetes Care 2016.
There are 2 dimensions to patient centeredness of diabetes care that Lonny Reisman, MD, the founder and chief executive officer of HealthReveal, will focus on during his keynote speech at Patient-Centered Diabetes Care 2016. To learn more about the conference and register now, click here.
Transcript (slightly modified)
As the keynote speaker for Patient-Centered Diabetes Care 2016, what will be the focus of your presentation?
I'm very excited about the Patient-Centered Diabetes Care symposium. I think the first thing that I will focus on relates to the need for patient centeredness when we're dealing with specific disease states like diabetes. And I think there are 2 dimensions to patient centeredness that I would like to focus on. One is a physiologic or clinical perspective, which not only relates to diabetes and sugar control but in a more holistic and comprehensive way the other components of diabetes management that relate to comorbidities and complications that can occur in a diabetic. So issues like lipid control, blood pressure control, smoking, activity and exercise, which fundamentally can alter the well-being of a diabetic patient.
The other dimension, I think, relates to the behaviors and engagement of the particular patient. So from a clinical perspective we can access the best evidence and the best technologies to define an optimal clinical path for a patient. Having said that, if the patient doesn't adequately engage and adhere to it, then all of our efforts are really for nothing. So I think there's a real need from a behavioral economist's perspective to make sure that patients are engaged and are complying with the guidance that we can generate on the clinical side.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More